Cargando…
NCAPG promotes the oncogenesis and progression of non-small cell lung cancer cells through upregulating LGALS1 expression
BACKGROUND: Numerous common oncogenic driver events have been confirmed in non-small cell lung cancer (NSCLC). Although targeted therapy has revolutionized NSCLC treatment, some patients still do not respond. NCAPG, also known as non-SMC condensin I complex subunit G, was positively associated with...
Autores principales: | Sun, Huanhuan, Zhang, Hong, Yan, Yan, Li, Yushi, Che, Gang, Zhou, Cuiling, Nicot, Christophe, Ma, Haiqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855584/ https://www.ncbi.nlm.nih.gov/pubmed/35180865 http://dx.doi.org/10.1186/s12943-022-01533-9 |
Ejemplares similares
-
Correction: NCAPG promotes the oncogenesis and progression of non-small cell lung cancer cells through upregulating LGALS1 expression
por: Sun, Huanhuan, et al.
Publicado: (2022) -
NCAPG Promotes Tumor Progression and Modulates Immune Cell Infiltration in Glioma
por: Zheng, Guangrong, et al.
Publicado: (2022) -
LGALS1 regulates cell adhesion to promote the progression of ovarian cancer
por: Li, Xuejian, et al.
Publicado: (2023) -
Upregulation of LGALS1 is associated with oral cancer metastasis
por: Li, Ji-Min, et al.
Publicado: (2018) -
NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway
por: Wu, Yun, et al.
Publicado: (2021)